DRTS — Alpha Tau Medical Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1871321 ·
Last close
$11.79
Market Cap
$1.06B
52W High
$14.11
52W Low
$7.17
ADV30
773,263
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -13,313,000 | -22,939,000 | 108,773,000 | 4,636,000 | 39,421,000 |
| Dec 2025 | 0 | — | -12,602,000 | -12,136,000 | 105,652,000 | 12,202,000 | 28,553,000 |
| Sep 2025 | 0 | — | -10,730,000 | -11,686,000 | 104,694,000 | 3,329,000 | 27,110,000 |
| Jun 2025 | 0 | — | -9,648,000 | -10,114,000 | 110,954,000 | 11,703,000 | 24,331,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-190,136,000
Inventory
—
Receivables
$336,000
ST Investments
$60,924,000
EBIT TTM
$-42,159,000
Pretax Income TTM
$-42,506,000
Interest Exp TTM
—
Analysts
4
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -42,288,000 | -42,627,000 | 105,652,000 | 28,553,000 | — | -26,681,000 |
| Dec 2024 | 0 | -36,042,000 | -31,750,000 | 86,204,000 | 23,538,000 | — | -19,783,000 |
| Dec 2023 | 0 | -35,680,000 | -29,157,000 | 107,388,000 | 22,913,000 | — | -17,958,000 |
| Dec 2022 | 0 | -32,136,000 | -33,762,000 | 120,149,000 | 14,492,000 | — | -23,879,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.51
Max Pain — expiry 2026-08-21
max pain strike: $10.00 · spot: $11.79 · call oi: 5,980 · put oi: 1,829
Expected Move to 2026-08-21:
±$2.02
(17.18%) —
implied range
$9.76 –
$13.81
· ATM straddle on $12.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PRCT | PROCEPT BioRobotics Corp | $1.06B | $18.62 | — |
| STVN | Stevanato Group S.p.A. | $986.74M | $19.85 | — |
| IRMD | IRADIMED CORP | $1.16B | $90.86 | — |
| AVNS | AVANOS MEDICAL, INC. | $1.17B | $24.99 | — |
| BVS | Bioventus Inc. | $892.24M | $13.17 | — |
News headlines (Yahoo Finance, 1h cache)
Alpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Success In Alpha DaRT Combo Trial
2026-08-01 06:16 · Yahoo
Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic H
2026-07-21 12:30 · Yahoo
Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center
2026-07-15 12:30 · Yahoo
New Strong Sell Stocks for July 7th
2026-07-07 12:31 · Yahoo
New Strong Sell Stocks for July 2nd
2026-07-02 07:49 · Yahoo
Alpha Tau Medical’s (DRTS) First International Brain Cancer Use Tests The Breadth Of Its Alpha DaRT Platform
2026-06-27 19:06 · Yahoo
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
2026-06-25 15:35 · Yahoo
Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel
2026-06-23 12:30 · Yahoo
Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
2026-06-11 12:30 · Yahoo
DRTS Stock Shot Up A Whopping 22% Today – Why A $196.5M Prostate Cancer Deal Got Investors Buzzing
2026-06-03 14:52 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.